NEW YORK (Reuters Health) – Overall outcomes of drug-eluting coronary stent (DES) implantation are statistically no worse with 6 months of dual antiplatelet therapy than with 12 months,…
NEW YORK (Reuters Health) Pooled data from four relatively small but high-quality prospective randomized controlled studies suggest an advantage to intracoronary (IC) over intravenous (IV) administration of abciximab…
NEW YORK (Reuters Health) – About 1 in 7 patients 60 years of age or older with heart failure undergoing intensive medical therapy have hyperkalemia, and one risk…
NEW YORK (Reuters Health) – Lowering blood pressure in patients with prehypertensive blood pressure significantly reduces the risk of stroke, according the results of a meta-analysis reported in…
NEW YORK (Reuters Health) – Performing percutaneous coronary interventions for coronary artery disease is feasible before transcatheter aortic valve implantation (TAVI), and the strategy appears safe, according to…
NEW YORK (Reuters Health) – Results of a dose-ranging study indicate that a medium dose of sildenafil given for 16 weeks improves peak oxygen consumption in children with…
NEW YORK (Reuters Health) – High-dose daptomycin appears to be a safe and effective therapeutic option for cardiac implantable electronic device (CIED)-related infective endocarditis due to staphylococci, clinicians…
NEW YORK (Reuters Health) – Results of an updated meta-analysis indicate that there are no clinically relevant differences in efficacy or effectiveness among second-generation antidepressants used to treat…
NEW YORK (Reuters Health) – Of the three modalities available for treating native coarctation of the aorta, balloon angioplasty yields less favorable outcomes than surgical correction or stenting,…
NEW YORK (Reuters Health) – Delays in treatment may favor onsite fibrinolytic therapy over transfer for primary percutaneous coronary intervention (PCI) in some patients who present with ST-segment-elevation…